OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8625
Results
Show all
Save search
Copy query
Show results for
Unknown
(8395)
Transcriptomics
(88)
Genomics
(66)
Proteomics
(52)
Clinical
(17)
Metabolomics
(6)
Models
(1)
Multiomics
(1)
Organisms
Homo sapiens
(45)
Mus musculus
(44)
Arabidopsis thaliana
(10)
Bos taurus
(6)
Rattus norvegicus
(5)
Oryza sativa
(4)
Pseudomonas putida
(4)
Gallus gallus
(3)
Saccharomyces cerevisiae
(2)
Drosophila melanogaster
(2)
Komagataella pastoris
(1)
Ovis aries
(1)
Canis lupus familiaris
(1)
Rattus rattus
(1)
262981
(1)
Kluyveromyces lactis NRRL Y-1140
(1)
Saccharomyces mikatae IFO 1815
(1)
Organisms
Homo sapiens
(36)
Mus musculus
(18)
biofilm metagenome
(1)
mouse gut metagenome
(1)
Rattus norvegicus
(1)
Repository
biostudies-arrayexpress
(86)
ENA
(63)
pride
(24)
jPOST
(17)
MassIVE
(7)
geo
(5)
MetabolomicsWorkbench
(4)
PAXDB
(4)
MetaboLights
(2)
BioModels
(1)
Tissue
Cell culture
(8)
Brain
(6)
Adipose tissue
(4)
Brain
(4)
Liver
(4)
Muscle
(4)
Embryo
(2)
Embryonic stem cell
(2)
B cell
(1)
Cerebrospinal fluid
(1)
Duodenum
(1)
Microglial cell
(1)
Testis
(1)
Disease
Colorectal cancer
(7)
Colorectal Neoplasms
(6)
Alzheimer's disease
(5)
Metastatic pancreatic cancer
(2)
Exposed_Seronegative
(1)
Carcinoma
(1)
Neoplasm Metastasis
(1)
Amyotrophic lateral sclerosis
(1)
Celiac disease
(1)
Primary ciliary dyskinesia
(1)
Technology Type
Mass Spectrometry
(28)
Shotgun proteomics
(15)
ESI
(4)
Affinity purification coupled with mass spectrometry proteomics
(4)
SRM/MRM
(4)
Bottom-up proteomics
(3)
Data-dependent acquisition
(3)
Mass spectrometry
(1)
NMR spectroscopy
(1)
Gel-based experiment
(1)
HDMSE
(1)
Instrument Platform
NextSeq 500
(9)
Q Exactive
(4)
Q TRAP
(4)
Q Exactive HF
(3)
Illumina NovaSeq 6000
(2)
Orbitrap Exploris 480
(1)
Orbitrap Fusion
(1)
Orbitrap Fusion Lumos
(1)
Liquid Chromatography MS - negative - reverse phase
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
Nuclear Magnetic Resonance (NMR)
(1)
Publication Date
2021
(16)
2016
(12)
2015
(12)
2013
(11)
2024
(11)
2011
(10)
2008
(10)
2014
(9)
2009
(9)
2023
(7)
2020
(7)
2012
(6)
2010
(6)
2026
(5)
2025
(5)
2022
(3)
2017
(3)
2019
(2)
2018
(2)
UNIPROT ID/AC
2A5D_YEAST
(2)
2AAA_YEAST
(2)
2ABA_YEAST
(2)
3HAO_YEAST
(2)
6P21_YEAST
(2)
6PGD1_YEAST
(2)
AAKG_YEAST
(2)
AAP1_YEAST
(2)
AATC_YEAST
(2)
AATM_YEAST
(2)
AB140_YEAST
(2)
ABF1_KLULA
(2)
ABF1_YEAST
(2)
ABF2_YEAST
(2)
ABP1_YEAST
(2)
ACA2_YEAST
(2)
ACAC_YEAST
(2)
ACBP_YEAST
(2)
ACE2_YEAST
(2)
ACEA_KLULA
(2)
ACF4_YEAST
(2)
ACH1_YEAST
(2)
ACL4_YEAST
(2)
ACM1_YEAST
(2)
ACO1_YEAST
(2)
ACON2_YEAST
(2)
ACON_YEAST
(2)
ACS1_KLULA
(2)
ACS1_YEAST
(2)
ACS2_KLULA
(2)
CHEBI ID
CHEBI:17154
(2)
CHEBI:27897
(2)
CHEBI:64399
(2)
CHEBI:13389
(1)
CHEBI:15344
(1)
CHEBI:15346
(1)
CHEBI:15351
(1)
CHEBI:15354
(1)
CHEBI:15366
(1)
CHEBI:15414
(1)
CHEBI:15422
(1)
CHEBI:15428
(1)
CHEBI:15674
(1)
CHEBI:15724
(1)
CHEBI:15741
(1)
CHEBI:15763
(1)
CHEBI:15891
(1)
CHEBI:15927
(1)
CHEBI:15940
(1)
CHEBI:16027
(1)
CHEBI:16135
(1)
CHEBI:16171
(1)
CHEBI:16199
(1)
CHEBI:16335
(1)
CHEBI:16449
(1)
CHEBI:16474
(1)
CHEBI:16675
(1)
CHEBI:16680
(1)
CHEBI:16704
(1)
CHEBI:16761
(1)
Metabolite Name
2-oxoglutarate
(1)
Cadaverine
(1)
Choline
(1)
Cis-aconitic acid
(1)
Citric acid
(1)
Fumarate
(1)
Isobutyric acid
(1)
Kynurenine
(1)
N-methylnicotinamide
(1)
Phenylalanine
(1)
Putrescine
(1)
Succinic acid
(1)
Tartarate
(1)
Taurine
(1)
Threonine
(1)
Trimethylamine N-oxide
(1)
Tryptophan
(1)
Tryptophan
(1)
Urea
(1)
Valine
(1)
First Public Date
2017
(11)
2026
(8)
2018
(8)
2021
(7)
2024
(6)
2014
(6)
2025
(5)
2022
(4)
2015
(4)
2023
(2)
2016
(2)
Modelling Approach
Ordinary differential equation model
(1)
Study status
Completed
(13)
Recruiting
(2)
Active, not recruiting
(1)
Terminated
(1)
Lab affiliation
Department of Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA
(5)
School of Agriculture, Meiji University
(4)
CECAD Institute, University of Cologne Joseph-Stelzmann-Straße 26 50931 Cologne Germany
(1)
CECAD Research Center, University of Cologne (Institute for Genetics) Joseph-Stelzmann-Str. 26 50931 Cologne Germany
(1)
Department of Immunology, University of Oslo, Norway
(1)
Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuoku, Kumamoto 860-8556, Japan
(1)
Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
(1)
Department of Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Martinsried, Germany
(1)
Department of Virology III, National Institute of Infectious Diseases
(1)
Forschungsinstitut für Frauengesundheit Universitäts- Frauenklinik Universitätsklinikum Tübingen Germany
(1)
Institute of Medical Biochemistry and Molecular Biology, University Medicine Greifswald, 17475, Greifswald, Germany
(1)
Northeastern University
(1)
Proteomics program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark
(1)
Shenzhen University, China
(1)
UT Southwestern Medical Center
(1)
University of Edinburgh
(1)
kochi university
(1)
Tags
xref:PubMed:30013029
(3)
xref:PubMed:28522454
(3)
xref:PubMed:34524860
(2)
xref:PubMed:28041875
(2)
xref:PubMed:29669006
(2)
xref:PubMed:35015831
(2)
xref:PubMed:42467615
(2)
xref:PubMed:38598342
(1)
xref:PubMed:32389496
(1)
xref:PubMed:40945669
(1)
xref:PubMed:38711503
(1)
xref:PubMed:35226739
(1)
xref:PubMed:38213786
(1)
xref:PubMed:29719619
(1)
xref:PubMed:28111276
(1)
xref:PubMed:41532473
(1)
xref:PubMed:27903753
(1)
xref:PubMed:25711920
(1)
xref:PubMed:27397436
(1)
xref:PubMed:23974043
(1)
xref:PubMed:19925653
(1)
xref:PubMed:38719621
(1)
xref:PubMed:30742779
(1)
xref:PubMed:28025139
(1)
xref:PubMed:28892104
(1)
xref:PubMed:42811341
(1)
xref:PubMed:29769258
(1)
xref:PubMed:28704514
(1)
xref:PubMed:22687993
(1)
xref:PubMed:35304548
(1)
Keyword
Panitumumab
(6)
Fluorouracil
(4)
Leucovorin
(4)
Oxaliplatin
(4)
Bevacizumab
(3)
Calcium
(3)
Calcium, Dietary
(3)
Levoleucovorin
(3)
Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab
(2)
Bispecific
(1)
CD3
(1)
CD3-Bispecific
(1)
CRC
(1)
Cetuximab
(1)
Drug therapy
(1)
EGFR
(1)
EGFR expressing cancers
(1)
Fluorouracil Injection
(1)
HNSCC
(1)
Human recombinant MIF antibody
(1)
Irinotecan
(1)
Metastatic cancer
(1)
Metastatic colorectal cancer, Panitumumab, TAS-102
(1)
Metastatic colorectal cancer, Panitumumab, mFOLFOX6, First-line
(1)
Mitomycin C
(1)
SCCHN
(1)
Squamous head and neck cancer
(1)
Unresectable locally advanced cancer
(1)
IsPrivate
False
(1)
Study type
Transcription profiling by array
(64)
Interventional
(14)
Animal - High-throughput sequencing
(3)
Transcription profiling by tiling array
(3)
RNA-seq of total RNA
(3)
RNA-seq of non coding RNA
(3)
Observational
(3)
Comparative genomic hybridization by array
(2)
ATAC-seq
(2)
ChIP-seq
(2)
RNA-seq of coding RNA
(2)
ChIP-chip by tiling array
(1)
RNA-seq of coding RNA from single cells
(1)
Release Date
2022
(1045)
2021
(980)
2023
(915)
2025
(864)
2024
(860)
2020
(808)
2019
(626)
2018
(515)
2017
(397)
2016
(351)
2015
(247)
2014
(158)
2026
(154)
2013
(119)
2011
(71)
2012
(71)
2010
(65)
2009
(49)
2008
(48)
2007
(31)
2005
(26)
2006
(14)
2004
(13)
2002
(13)
2001
(11)
2003
(10)
2000
(9)
1998
(6)
1999
(3)
Location
Japan
(14)
United States
(3)
North America
(2)
Australia
(1)
Germany
(1)
South Korea
(1)
Spain
(1)
United Kingdom
(1)
Previous
page
1 / 863
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
863
Next
page
Sort
by:
Relevance
Page size
10
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
Not available
S-EPMC8252548
|
biostudies-literature
Cite
Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B.
Not available
S-EPMC7444148
|
biostudies-literature
Cite
Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial.
Not available
S-EPMC6852556
|
biostudies-literature
Cite
A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults.
Not available
S-EPMC10739571
|
biostudies-literature
Cite
A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
Not available
S-EPMC5784926
|
biostudies-literature
Cite
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
Not available
S-EPMC7383916
|
biostudies-literature
Cite
Tolerability and Safety of Large-Volume Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administered with or without Dose Ramp-Up: A Phase 1 Study in Healthy Participants.
Not available
S-EPMC11186899
|
biostudies-literature
Cite
Physiologically based and population PK modeling in optimizing drug development: A predict-learn-confirm analysis.
Not available
S-EPMC5039936
|
biostudies-literature
Cite
How Full-Length FVIII Benefits from Its Heterogeneity - Insights into the Role of the B-Domain.
Not available
S-EPMC6443606
|
biostudies-literature
Cite
The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
Not available
S-EPMC4989286
|
biostudies-literature
Cite
Previous
page
1 / 863
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
863
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
